Patoloxía Molecular das Doenzas Raras
PatMol-DR
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (11)
2025
2024
-
Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study
The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 3, pp. e932-e944
-
The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease
European Heart Journal Open, Vol. 4, Núm. 2
2023
-
Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy
Diabetes, Vol. 72, Núm. 1, pp. 71-84
2022
-
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry
European journal of preventive cardiology, Vol. 29, Núm. 6, pp. 859-868
-
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study
International Journal of Cardiology, Vol. 361, pp. 116-123
2021
-
Complement factor d (Adipsin) levels are elevated in acquired partial lipodystrophy (barraquer–simons syndrome)
International Journal of Molecular Sciences, Vol. 22, Núm. 12
2020
-
Correction: Immunological features of patients affected by Barraquer-Simons syndrome (Orphanet Journal of Rare Diseases DOI: 10.1186/s13023-019-1292-1)
Orphanet Journal of Rare Diseases
-
Evidence of ongoing complement activation on adipose tissue from an 11-year-old girl with Barraquer–Simons syndrome
Journal of Dermatology, Vol. 47, Núm. 12, pp. 1439-1444
-
Immunological features of patients affected by Barraquer-Simons syndrome
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
2018
-
Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy
Frontiers in Immunology, Vol. 9, Núm. SEP